Post Profile

UC San Diego Health Joins Precision Medicine Initiative to Tackle Pancreatic Cancer

Physician-scientists with Moores Cancer Center at UC San Diego Health have been leading the way in pancreatic cancer care by investigating new therapies as well as offering innovative clinical trials and the latest treatments with a personalized medicine approach. This expertise led to the selection of Moores Cancer Center as one of 12 clinical trial sites for the Pancreatic Cancer Action Network's newly created Precision Promise.
read more


Related Posts

First Precision Medicine Trial in Cancer Prevention Identifies Molecular-Based Chemoprevention Strategy

Health : Newswise Medical News

A team of scientists, led by researchers at The University of Texas MD Anderson Cancer Center and University of California, San Diego Moores Cancer Center, report that a genetic biomarker called loss of heterozygosity or LOH is able...

Fred Hutch Selected to Join National Effort to Transform Treatment for Pancreatic Cancer Patients

Health : Newswise Medical News

Today the Pancreatic Cancer Action Network announced Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer by tailoring their treatment to their cancer's...

UC San Diego Health Researchers Join Pancreatic Cancer "Dream Team"

Health : Newswise Medical News

University of California, San Diego School of Medicine researchers Andrew Lowy, MD, and Tannishtha Reya, PhD, have been recruited for their expertise in preclinical modeling, clinical trials and stem cell biology to join a "dream te...

Immunotherapy drug a 'gamechanger' for head and neck cancer

Health : The Guardian: Health

Nivolumab found to extend lives of relapsed patients who had run out of therapy options An immunotherapy drug hailed as a potential “gamechanger” in the treatment of cancer could soon offer new hope to patients with currently untrea...

UC San Diego Health Joins National Clinical Trial on Hemophilia B Gene Therapy

Health : Newswise Medical News

The Hemophilia and Thrombosis Treatment Center at UC San Diego Health has joined a nationwide clinical trial testing a potential gene therapy that may one day provide a better and long-lasting treatment for people with hemophilia B.


Copyright © 2016 Regator, LLC